Notwithstanding, this finding further supports the potential relevance of considering the use of AMH for diagnosing and grading PCOS severity, in line with the growing trend of international groups working towards the refinement of the 2003 Rotterdam criteria (Teede et al., 2023). This evidence concerns the gene AMH and polycystic ovary syndrome.